ACKR3
ACKR3 (Atypical Chemokine Receptor 3), also known as CXCR7, is a protein that in humans is encoded by the ACKR3 gene. This protein is a member of the G protein-coupled receptor family, and functions as a chemokine receptor.
Function[edit]
ACKR3 is a receptor for the chemokine CXCL12/SDF1 and the interleukin IL-3. It is involved in cell migration, cell proliferation, and cell survival. It is also involved in the regulation of immune responses, hematopoiesis, and embryogenesis.
Clinical significance[edit]
Alterations in the ACKR3 gene have been associated with various diseases, including cancer, cardiovascular disease, and inflammatory diseases. In cancer, ACKR3 has been implicated in tumor growth, angiogenesis, and metastasis. In cardiovascular disease, it has been associated with atherosclerosis, myocardial infarction, and heart failure. In inflammatory diseases, it has been linked to rheumatoid arthritis, asthma, and inflammatory bowel disease.
Research[edit]
Research is ongoing to develop drugs that target ACKR3 for the treatment of these diseases. Several small molecules and antibodies that bind to and inhibit ACKR3 have been identified, and some are in clinical trials.
See also[edit]
| Cytokine receptors | ||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
| Human Proteins | ||||||||
|---|---|---|---|---|---|---|---|---|
This human proteins-related article is a stub. You can help WikiMD by expanding it.
|
| Genetics and Genomics | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
|
 | This medical article is a stub. You can help WikiMD by expanding the page. |
Sponsored Health Resource
W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
